Company Name: Eidos Therapeutics, Inc.

Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company’s area of therapeutic focus is on diseases caused by transthyretin amyloidosis.

Ticker Symbol: EIDX (NASDAQ)

Company Website: https://eidostx.com

Social Media:

Eidos Therapeutics Linkedin

Headquarters: San Francisco, CA